Aeglea Biotherapeutics shares owned by ProFund Advisors
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by ProFund Advisors
from 13F filings
Historical chart of ProFund Advisors investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by ProFund Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv![Download consolidated filings csv](/static/img/csv.png)
![Download consolidated filings xlsx](/static/img/microsoft-excel.png)
Quarterly reported holdings in Aeglea Biotherapeutics by ProFund Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-12-31 | $346k | 15k | 23.28 |
2024-09-30 | $414k | 14k | 29.41 |
2024-06-30 | $296k | 13k | 23.51 |